Molecular Profiling of Advanced Malignancies: A Community Oncology Network Experience and Review of Literature
Background: Many genomic alterations have been identified that are critical to the malignant phenotype. Some of these, termed “driver mutations,” are critical for tumor proliferation and progression. The landscape of targeted therapy has expanded as well. Next-generation sequencing (NGS) of tumors r...
Main Authors: | Pritam Tayshetye, Katherine Miller, Dulabh Monga, Candice Brem, Jan F. Silverman, Gene Grant Finley |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2020-07-01
|
Series: | Frontiers in Medicine |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fmed.2020.00314/full |
Similar Items
-
Precision oncology: lessons learned and challenges for the future
by: Yang HT, et al.
Published: (2019-08-01) -
Precision Genomic Practice in Oncology: Pharmacist Role and Experience in an Ambulatory Care Clinic
by: Farah Raheem, et al.
Published: (2020-03-01) -
Recent Progress in the Systemic Treatment of Advanced/Metastatic Cholangiocarcinoma
by: Raluca Maria Fostea, et al.
Published: (2020-09-01) -
Comprehensive characterization reveals sputum supernatant as a valuable alternative liquid biopsy for genome profiling in advanced non-small cell lung cancer
by: Chen, Z., et al.
Published: (2022) -
Pharmacogenomic Testing to Guide Personalized Cancer Medicine Decisions in Private Oncology Practice: A Case Study
by: George Astras, et al.
Published: (2020-04-01)